Diagnostic and Pathophysiological Impact of Myocardial MIBG Scintigraphy in Parkinson's Disease

Author

Spiegel, Jörg

Source

Parkinson’s Disease

Issue

Vol. 2010, Issue 2010 (31 Dec. 2010), pp.1-6, 6 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2009-11-22

Country of Publication

Egypt

No. of Pages

6

Main Subjects

Diseases
Medicine

Abstract EN

Myocardial MIBG scintigraphy is established in the diagnosis and differential diagnosis of Parkinson's disease (PD).

Numerous studies address the pathophysiological impact of myocardial MIBG scintigraphy: the myocardial MIBG uptake correlates with the clinical phenotype of PD; the background of this phenomenon is unclear.

Furthermore MIBG scintigraphy enables to study the extracranial Lewy body type-degeneration.

In combination with cerebral dopamine transporter imaging, MIBG scintigraphy allows to correlate cerebral and extracranial Lewy body type-degeneration in PD.

American Psychological Association (APA)

Spiegel, Jörg. 2009. Diagnostic and Pathophysiological Impact of Myocardial MIBG Scintigraphy in Parkinson's Disease. Parkinson’s Disease،Vol. 2010, no. 2010, pp.1-6.
https://search.emarefa.net/detail/BIM-989700

Modern Language Association (MLA)

Spiegel, Jörg. Diagnostic and Pathophysiological Impact of Myocardial MIBG Scintigraphy in Parkinson's Disease. Parkinson’s Disease No. 2010 (2010), pp.1-6.
https://search.emarefa.net/detail/BIM-989700

American Medical Association (AMA)

Spiegel, Jörg. Diagnostic and Pathophysiological Impact of Myocardial MIBG Scintigraphy in Parkinson's Disease. Parkinson’s Disease. 2009. Vol. 2010, no. 2010, pp.1-6.
https://search.emarefa.net/detail/BIM-989700

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-989700